COVID-19: Pharma on the frontline
Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
Opportunity to transform NHS customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, talks about the impact of coronavirus on NHS customer engagement. As the first wave of COVID-19 subsides in...
Health Technology Assessment Post-COVID
Claudia Rubin, Director at Decideum, questions what will Health Technology Assessment look like post-COVID? As England and the devolved nations emerge from COVID-19 lockdown at...
Rapid change COVID-19 & UK clinical research
Dr Matthew Hallsworth, Head of External Relations at the National Institute for Health Research, looks how COVID-19 has brought about rapid change of clinical...
Accelerated use of electronic prescribing
Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
Remote engagement with HCPs after COVID-19
Mick O’Leary, Regional President of Ashfield Commercial and Patient Solutions, looks at how the pharmaceutical industry can create a vision for the ‘new normal’...
Addressing the long-term effects of COVID-19
Johnny Skillicorn-Aston and Jeremy Hooper address the long-term effects of COVID-19 and preventing a negative legacy amongst the population. Addressing the long-term impacts on sickness...
COVID-19: changing the pharma workforce
There’s no denying the COVID-19 has changed the world, but will it have a lasting effect on the pharma workforce? Graham Hawthorn
Managing Director, CHASE It is...
UK COVID-19 rapid antibody tests approved for professional use & commercial distribution
A COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark....
GSK & Sanofi strike deal to supply UK with up to 60m doses of...
Sanofi and GSK have reached an agreement* with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. Developed...
Latest articles
Consumers turn to community pharmacists during COVID-19
Research commissioned by Johnson & Johnson (J&J) Consumer Health EMEA and conducted by Ipsos MORI has revealed that COVID-19 has seen UK consumers look...
Funding for new precision cancer treatment
Sixfold Bioscience and Medicines Discovery Catapult have been awarded an Innovate UK grant to pursue a ground-breaking project on new precision cancer treatment technology. The...
Pharmaspectra enters partnership with IBM Watson Health
Pharmaspectra, the world’s largest collection of medical science, today announced it has entered into a partnership with IBM Watson Health. Through the partnership agreement, IBM Watson...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Consumers turn to community pharmacists during COVID-19
Research commissioned by Johnson & Johnson (J&J) Consumer Health EMEA and conducted by Ipsos MORI has revealed that COVID-19 has seen UK consumers look...
Pharmaspectra enters partnership with IBM Watson Health
Pharmaspectra, the world’s largest collection of medical science, today announced it has entered into a partnership with IBM Watson Health. Through the partnership agreement, IBM Watson...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
Funding for new precision cancer treatment
Sixfold Bioscience and Medicines Discovery Catapult have been awarded an Innovate UK grant to pursue a ground-breaking project on new precision cancer treatment technology. The...